Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
AUTOR(ES)
García-Colunga, J.
FONTE
The National Academy of Sciences of the USA
RESUMO
Fluoxetine (Prozac), a widely used antidepressant, is said to exert its medicinal effects almost exclusively by blocking the serotonin uptake systems. The present study shows that both muscle and neuronal nicotinic acetylcholine receptors are blocked, in a noncompetitive and voltage-dependent way, by fluoxetine, which also increases the rate of desensitization of the nicotinic receptors. Because these receptors are very widely distributed in the both central and peripheral nervous systems, the blocking action of fluoxetine on nicotinic receptors may play an important role in its antidepressant and other therapeutical effects. Our findings will help to understand the mode of action of fluoxetine, and they may also help to develop more specific medicinal drugs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20039Documentos Relacionados
- Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac)
- Neuronal Nicotinic Acetylcholine Receptors and Epilepsy
- Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)
- A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors
- Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors.
